Amantadine: all 71 studies that test it

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer PatientsNot yet recruitingNCT07889115Phase 2
• Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain SyndromeRecruitingNCT07421427Not applicable
• Use of Gocovri to Improve Disability Due to Radiation EncephalopathyNot yet recruitingNCT07125222Phase 2
• Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple SclerosisRecruitingNCT05809414Phase 3
• Amantadine for Neuroenhancement in Acute Patients StudyRecruitingNCT05479032Phase 2
• Promoting Recovery After STroke With AmantadineRecruitingNCT05140148Phase 2
• Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant DepressionRecruitingNCT04936126Phase 4
• Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialRecruitingNCT04302870Phase 2/3
• Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's DiseaseCompletedNCT04387773Phase 4Results posted
• Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral PalsyTerminatedNCT04273737Phase 4Results posted
• Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple SclerosisCompletedNCT03185065Phase 3Results posted
• Amantadine to Speed Awakening After Cardiac ArrestCompletedNCT02486211Phase 2Results posted
• Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.TerminatedNCT02153645Phase 3Results posted
• Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LIDTerminatedNCT02153632Phase 3Results posted
• Amantadine + rTMS as a Neurotherapeutic for Disordered ConsciousnessCompletedNCT02025439Not applicableResults posted
• Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's DiseaseTerminatedNCT01652534Phase 3Results posted
• Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for ComplicationsCompletedNCT01227967Phase 2Results posted
• Validation of Dyskinesia Rating ScalesCompletedNCT01071395Phase 4Results posted
• Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin ElevationTerminatedNCT00975611Phase 4Results posted
• Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI)CompletedNCT00970944Phase 2/3Results posted
• TCAD vs. Monotherapy for Influenza A in Immunocompromised PatientsCompletedNCT00867139Phase 1/2Results posted
• Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's DiseaseTerminatedNCT00794313Not applicableResults posted
• Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site StudyCompletedNCT00779324Not applicableResults posted
• Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapineCompletedNCT00401973Phase 3Results posted
• A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's DiseaseCompletedNCT07113015Not applicable
• Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain SyndromeCompletedNCT06833203Not applicable
• Effect of Intravenous Amantadine Sulphate on Disorders of ConsciousnessActive, not recruitingNCT06443827Phase 2
• Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).Active, not recruitingNCT06253923Phase 2
• A Study of Amantadine for Cognitive Dysfunction in Patients With Long-CovidWithdrawnNCT06234462Phase 2
• Amantadine Therapy for Cognitive Impairment in Long COVIDCompletedNCT06055244Phase 2
• Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICUCompletedNCT06052787Phase 3
• The Effect of Amantadine on Post-COVD-19 FatigueStatus unknownNCT05667077Phase 2
• Efficacy of Amantadine Treatment in COVID-19 PatientsTerminatedNCT04952519Phase 3
• Amantadine for COVID-19Status unknownNCT04894617Phase 3
• The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 SymptomsStatus unknownNCT04854759Phase 3
• Impact of Amantadine on Traumatic Brain InjuryCompletedNCT04527289Phase 4
• Changes in Glutamatergic Neurotransmission of Severe TBI PatientsSuspendedNCT04244058Early Phase 1
• Evaluation of the Effect of Preoperative Intravenous Amantadine Sulfate on the Postoperative Early Cognitive Functions in a Elderly Patient With Laparoscopic Radical ProstatectomyStatus unknownNCT03988010Phase 4
• Oral Amantadine, IV Amantadine and Hemodynamic Response to LaryngoscopyStatus unknownNCT03612921Phase 2
• Effects of Amantadine on Postoperative Cognitive DysfunctionStatus unknownNCT03527134Not applicable
• Citicholine-Amantadine Trial in Traumatic Brain InjuryCompletedNCT03430817Phase 4
• Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot StudyStatus unknownNCT02566720Not applicable
• Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain InjuryStatus unknownNCT02321761Phase 4
• Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's DiseaseCompletedNCT01538329Phase 2
• Urinary Excretion of Acetylamantadine by Normal Healthy VolunteersCompletedNCT01467258Not applicable
• Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes SubjectsCompletedNCT01441986Phase 2
• Effect of Intravenous Amantadine on Gait Freezing in Parkinson's DiseaseCompletedNCT01313845Phase 4
• Pilot Study of Maintenance Therapy With Intravenous AMANTADINEStatus unknownNCT01190553Not applicable
• Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)Status unknownNCT01099059Phase 2
• Amantadine as Adjunctive Therapy to Antipsychotics in SchizophreniaStatus unknownNCT00999505Phase 3
• Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised SubjectsCompletedNCT00979251Phase 2
• Amantadine for Improving Neurologic Symptoms in Ataxia-TelangiectasiaCompletedNCT00950196Phase 4
• Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A InfectionTerminatedNCT00830323Phase 2
• Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)WithdrawnNCT00800514Not applicable
• Amantadine for Treatment of Symptoms of the Post-traumatic Confusional StateCompletedNCT00693121Phase 4
• Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)CompletedNCT00632762Phase 4
• Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic IrritabilityCompletedNCT00627250Not applicable
• Perioperative Treatment of Parkinsonian Patients With Parenteral AmantadineTerminatedNCT00600093Phase 2
• Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With AmantadineCompletedNCT00416962Phase 1
• Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination TherapyStatus unknownNCT00299923Phase 3
• Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1
• Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected PatientsCompletedNCT00221624Phase 3
• Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical ProstatectomyStatus unknownNCT00188383Phase 1/2
• Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2CompletedNCT00158132Phase 2
• Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive PatientsCompletedNCT00146016Phase 3
• Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)Status unknownNCT00127777Phase 4
• Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)WithdrawnNCT00127114Phase 4
• Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
• Prepulse Inhibition of Startle in Cocaine Dependence - 7CompletedNCT00015249Phase 1
• Treatment of Huntington's Chorea With AmantadineCompletedNCT00001930Phase 2
• Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4CompletedNCT00000301Phase 2

← Amantadine overview